| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 01/13/2004 | US6677463 Single pot conversion of artemisinin to artesunic acid |
| 01/13/2004 | US6677456 As antitumor compound; can be orally administered |
| 01/13/2004 | US6677435 Includes an active therapeutic agent joined to a blocking moiety sensitive to the catalytic action of molecules having retro- aldol and retro-michael catalytic activity; antitumor; anticarcinogenic agents |
| 01/13/2004 | US6677357 Nerve growth factor; animal growth regulator; antitmor agent |
| 01/13/2004 | US6677338 Serotonin transport inhibitors |
| 01/08/2004 | WO2004003035A1 Unsaturated monomers, polymers, chemically amplified resist composition, and process of pattern formation |
| 01/08/2004 | WO2004002992A1 Compounds |
| 01/08/2004 | WO2004002975A1 PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO[2,3-b]FURAN-3-OL |
| 01/08/2004 | WO2004002935A1 Chiral dopant with phenylethanediol functionality |
| 01/08/2004 | WO2004002934A1 Dicarboxylic acids for dielectrics with barrier effect against copper diffusion |
| 01/08/2004 | WO2004002428A2 Derivatives of gambogic acid and induce apoptosis |
| 01/08/2004 | WO2003076445A3 Microtubule stabilizing compounds |
| 01/08/2004 | WO2002067239A3 Process for preparing intermediates of hiv protease inhibitors |
| 01/08/2004 | US20040006126 For therapy of cancer |
| 01/08/2004 | US20040006121 Total synthesis of merrilactone A |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | CA2491698A1 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 01/07/2004 | EP1377588A1 4-beta-1''-[(2''-(substituted benzoyl)anilino] podophyllotoxin analogues useful as anticancer agents |
| 01/07/2004 | CN1133637C Triptolide analogs and composition and use thereof |
| 01/06/2004 | US6673937 Analogs of deoxypreussomerin, palmarumycin cpi and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
| 01/06/2004 | US6673830 Compounds from plants of the genus calophyllum, methods of extraction and use as treatment for human immumodeficiency virus |
| 01/06/2004 | US6673816 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| 01/02/2004 | EP1375583A1 Diacetal composition, nucleating agent containing the composition for polyolefin, polyolefin resin composition containing the diacetal composition, process for producing the resin composition, and molded object |
| 01/02/2004 | EP1375488A1 Triptolide prodrugs having high aqueous solubility |
| 01/01/2004 | US20040002611 Synthesis of spiro esters, spiro ortho carbonates, and intermediates |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 12/31/2003 | WO2004000859A2 Etoposide analogs and methods of use thereof |
| 12/31/2003 | WO2004000844A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms |
| 12/31/2003 | WO2003089445A3 Simultaneous reaction and separation process for the manufacture of dianhydro sugar alcohols |
| 12/31/2003 | WO2003049746A3 Combination of cytochome p450 dependent protease inhibitors |
| 12/31/2003 | CN1132676C 用于降低血制品中小有机分子的方法和装置 For reducing blood products of small organic molecules method and apparatus |
| 12/31/2003 | CA2487544A1 Pyrazolopyrimidines |
| 12/30/2003 | US6670389 Laulimalide derivatives |
| 12/30/2003 | US6670383 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity |
| 12/30/2003 | US6670375 Particularly, 8-aza-, 8-carbo- and 8-oxo- tropanes having 6-or 7-substituents; preferred are the dopamine transporter, the serotonin transporter and the norepinephrine transporter. |
| 12/25/2003 | WO2003106461A2 Pseudopolymorphic forms of a hiv protease inhibitor |
| 12/25/2003 | US20030236167 Novel herbicides |
| 12/25/2003 | US20030235632 Heterocyclic ethers obtained from grapefruit juices, used as first pass effect antgonists; dietetics |
| 12/24/2003 | WO2003039454A3 Beta-secretase inhibitors and methods of use |
| 12/24/2003 | CN1462750A Erigeron ester B and its preparation method as well as application in pharmacy |
| 12/24/2003 | CN1462747A High molecular monomer of chemical amplification type light resistance agent compson. |
| 12/23/2003 | US6667408 Process for preparing cyclic polyethers |
| 12/18/2003 | WO2003103602A2 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/18/2003 | WO2003103588A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 12/18/2003 | WO2003103583A2 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 12/18/2003 | WO2003045933A3 Preparation and use of gamma-butyrolactones as cross-linking agents |
| 12/18/2003 | US20030233000 Bryostatin composition and bryostatin acquisition methodologies |
| 12/18/2003 | US20030232827 Therapeutic compounds |
| 12/18/2003 | US20030232809 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion |
| 12/18/2003 | CA2488609A1 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 12/18/2003 | CA2488360A1 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 12/18/2003 | CA2488347A1 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 12/18/2003 | CA2487414A1 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/17/2003 | EP1370543A2 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 12/17/2003 | EP1370213A2 Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same |
| 12/17/2003 | EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/17/2003 | CN1462274A Triazolo-epothilones |
| 12/17/2003 | CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides |
| 12/16/2003 | US6664281 Oxazol-4-yl-alkoxy- or alkthioxy- functionality; peroxisome proliferator activated receptor regulators |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/11/2003 | WO2003101951A2 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 12/11/2003 | US20030229235 Dehydration of the corresponding sugar alcohol using acid catalyst |
| 12/11/2003 | US20030229234 Hydrophilic polymers; bonding strength, chemical resistance |
| 12/10/2003 | EP1368030A1 Epothilone derivatives for the treatment of refractory tumors |
| 12/10/2003 | EP1368025A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 12/10/2003 | EP1163243B1 Calanolides for inhibiting btk |
| 12/10/2003 | EP0970086B1 Spiro compounds and the use thereof |
| 12/10/2003 | EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives |
| 12/10/2003 | CN1130366C Substituted phenylketoenols and preparing method, midbody and their use as pestcides and herbicides |
| 12/09/2003 | US6660766 Bioavailability |
| 12/09/2003 | US6660758 Epothilone analogs |
| 12/09/2003 | US6660732 Ureas and thioureas inhibit production of cytokines |
| 12/09/2003 | US6660731 Pyrazole compounds useful as protein kinase inhibitors |
| 12/09/2003 | US6660727 Photochromic heterocyclically anellated indenochromene compounds |
| 12/09/2003 | US6660529 Heteroaryl substituted benzothiazole dioxetanes |
| 12/09/2003 | US6660345 Thermochromic liquid crystalline medium |
| 12/09/2003 | US6660263 Mono-chlorinated lipophilic macrocyclic lactone isolated from a strain of Serratia marcescens that produces oocydin A in culture. |
| 12/04/2003 | WO2003099780A2 Luminogenic protease substrates |
| 12/04/2003 | WO2003099719A1 Microporous crystalline zeolite material (zeolite itq-22), synthesis method thereof and use of same as a catalyst |
| 12/04/2003 | WO2003099273A1 Adduct of topiramate and tramadol hydrochloride and uses thereof |
| 12/04/2003 | WO2003089420A3 Recovery and purification of anhydro sugar alcohols from a vapor stream |
| 12/04/2003 | WO2003082185A3 Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof |
| 12/04/2003 | WO2003010138A3 Piperidine derivatives as antibacterial agents |
| 12/04/2003 | US20030225157 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene |
| 12/04/2003 | US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 12/04/2003 | US20030225134 Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance |
| 12/04/2003 | US20030225077 Naphthylamines used to chronic inflammatory diseases. |
| 12/04/2003 | US20030225052 Containing a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety |
| 12/04/2003 | US20030224391 Rigidized trimethine cyanine dyes |
| 12/04/2003 | CA2486709A1 Adduct of topiramate and tramadol hydrochloride and uses thereof |
| 12/03/2003 | EP1367057A1 Epothilones C, E and F |
| 12/03/2003 | EP1366052A2 Novel multi-ring organic compounds for regulating gut motility and food intake |
| 12/03/2003 | CN1460107A Fluorinated and alkylated alditol derivatives and polyolefin articles containing same |
| 12/02/2003 | US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 12/02/2003 | US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 12/02/2003 | US6656939 Pyrazole compounds useful as protein kinase inhibitors |
| 12/02/2003 | US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes |
| 12/02/2003 | US6656711 Fermentative preparation process for and crystal forms of cytostatics |
| 12/02/2003 | CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them |